Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression
Clinical trial NCT02863718 · COMPLETED
Trial details
- NCT number
- NCT02863718
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-30
- Primary completion
- 2019-03-07
- Enrollment
- 515
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.